Raymond James & Associates’s Stantec STN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-63,700
Closed -$3.19M 4211
2022
Q1
$3.19M Buy
63,700
+1,857
+3% +$96.3K ﹤0.01% 1819
2021
Q4
$3.48M Sell
61,843
-6,063
-9% -$328K ﹤0.01% 1789
2021
Q3
$3.19M Sell
67,906
-2,294
-3% -$109K ﹤0.01% 1776
2021
Q2
$3.13M Sell
70,200
-1,893
-3% -$85.3K ﹤0.01% 1798
2021
Q1
$3.09M Sell
72,093
-2,009
-3% -$77.3K ﹤0.01% 1743
2020
Q4
$2.4M Buy
74,102
+432
+0.6% +$13.3K ﹤0.01% 1789
2020
Q3
$2.24M Buy
+73,670
New +$2.33M ﹤0.01% 1686
2017
Q2
Sell
-92,524
Closed -$2.4M 3432
2017
Q1
$2.4M Sell
92,524
-1,009
-1% -$26.5K 0.01% 1425
2016
Q4
$2.36M Buy
93,533
+812
+0.9% +$20.1K 0.01% 1383
2016
Q3
$2.18M Buy
92,721
+1,843
+2% +$44.2K 0.01% 1397
2016
Q2
$2.2M Buy
90,878
+7,000
+8% +$178K 0.01% 1276
2016
Q1
$2.13M Buy
83,878
+4,361
+5% +$100K 0.01% 1244
2015
Q4
$1.96M Sell
79,517
-463
-0.6% -$11.6K 0.01% 1276
2015
Q3
$1.75M Buy
79,980
+69
+0.1% +$1.75K 0.01% 1294
2015
Q2
$2.33M Buy
79,911
+1,145
+1% +$31.4K 0.01% 1228
2015
Q1
$1.91M Buy
78,766
+1,945
+3% +$49.3K 0.01% 1265
2014
Q4
$2.12M Buy
76,821
+1,025
+1% +$30.4K 0.01% 1123
2014
Q3
$2.48M Sell
75,796
-3,350
-4% -$109K 0.01% 991
2014
Q2
$2.44M Sell
79,146
-204
-0.3% -$6.17K 0.02% 982
2014
Q1
$2.43M Sell
79,350
-12,524
-14% -$380K 0.02% 923
2013
Q4
$2.87M Sell
91,874
-3,534
-4% -$107K 0.02% 770
2013
Q3
$2.43M Sell
95,408
-5,988
-6% -$142K 0.02% 778
2013
Q2
$2.14M Buy
+101,396
New +$2.15M 0.02% 776

Other funds holding STN

Raymond James & Associates's STN Position: Q2 2022 in Review

Raymond James & Associates sold out of Stantec (STN) in Q2 2022, closing a stake of 63,700 shares — an estimated $3.19M sold.

Raymond James & Associates first reported a position in STN in Q2 2013 and held it in 23 quarters. The position peaked at $3.48M in Q4 2021. 138 funds tracked by Wall St. Rank hold STN as of Q2 2022.

  • Raymond James & Associates reported no remaining Stantec position as of Q2 2022 after selling out during the quarter.
  • Raymond James & Associates sold 63,700 Stantec shares in Q2 2022, an estimated $3.19M.
  • Raymond James & Associates first reported a position in Stantec in Q2 2013 and held it in 23 quarters.
  • Raymond James & Associates's Stantec position peaked at $3.48M in Q4 2021.
  • 138 funds tracked by Wall St. Rank held Stantec as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.